Shares of CRH Medical Corp (TSE:CRH) have been assigned a consensus rating of “Buy” from the six analysts that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is C$4.19.
A number of research analysts have recently weighed in on CRH shares. National Bank Financial raised their target price on CRH Medical from C$4.25 to C$4.50 and gave the company an “outperform” rating in a report on Tuesday, March 6th. TD Securities raised their target price on CRH Medical from C$2.50 to C$3.50 and gave the company a “hold” rating in a report on Wednesday.
CRH Medical (TSE:CRH) traded down C$0.19 during mid-day trading on Tuesday, hitting C$3.86. The stock had a trading volume of 281,700 shares, compared to its average volume of 278,862. CRH Medical has a 52 week low of C$1.86 and a 52 week high of C$12.35. The company has a market capitalization of $280.91, a price-to-earnings ratio of 35.09 and a beta of 0.71.
CRH Medical Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.